Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913205887> ?p ?o ?g. }
- W2913205887 abstract "Introduction To evaluate the implementation and dosimetric outcomes of magnetic resonance imaging (MRI) planning for improved target and normal tissue definition for the treatment of prostate cancer with high-dose-rate brachytherapy (HDRBT). Methods From August 2015 to October 2017, 137 unique patients with newly diagnosed localized prostate cancer underwent a total of 174 outpatient brachytherapy procedures using MRI-based treatment planning. Patients receiving brachytherapy as monotherapy underwent two separate procedures while those receiving brachytherapy as a boost after external beam radiation therapy underwent a single procedure. The target volume was defined as the prostate +/- seminal vesicles as clinically appropriate without any additional margin. Pre-treatment dose-volume histogram (DVH) goals to the target were: D90≥95%, V90≥95%, V100≥90%, V150≤30%, V200≤15%. DVH goals to organs-at-risk (OARs): urethra D.01cc ≤115%, bladder D1cc ≤75%, rectum D1cc ≤75%, neurovascular bundle D0.1cc ≤100%, penile bulb D1cc ≤100%. Procedure times were recorded at each step of the procedure, from catheter insertion to removal. Results The median target volume was 45.9 cc, the median volume receiving the prescription dose was 53.0 cc, and the median selectivity index was 0.9. The median values for target dosimetry were as follows: D90=99.9%, V90=95.7%, V100=90.1%, V150=28.1%, V200=10.5%. The median values for OAR dosimetry were: urethra D.01cc=114.3%, bladder D1cc=68.3%, rectum D1cc=51.8%, left neurovascular bundle D0.1cc=86.8%, right neurovascular bundle D0.1cc=88.5%, penile bulb D1cc=31.7%. The median time from catheter insertion to end of HDRBT delivery was four hours 14 minutes (range 2:56-9:08); total treatment package time was five hours 32 minutes (range 3:31-9:45). Conclusion Routine MRI-based treatment planning is feasible for the delivery of HDRBT for prostate cancer. We met stringent dosimetric criteria despite more objective target and normal tissue definition with MRI imaging. Treatment package time remains reasonable. We have adopted MRI as our standard imaging modality for HDRBT for prostate cancer." @default.
- W2913205887 created "2019-02-21" @default.
- W2913205887 creator A5008727313 @default.
- W2913205887 creator A5029947606 @default.
- W2913205887 creator A5030221717 @default.
- W2913205887 creator A5033055858 @default.
- W2913205887 creator A5037101951 @default.
- W2913205887 creator A5072025238 @default.
- W2913205887 creator A5073004665 @default.
- W2913205887 creator A5073891143 @default.
- W2913205887 creator A5080360470 @default.
- W2913205887 creator A5087919687 @default.
- W2913205887 date "2019-02-16" @default.
- W2913205887 modified "2023-10-02" @default.
- W2913205887 title "Incorporating Routine Magnetic Resonance Imaging-based Planning for the Delivery of High-dose-rate Brachytherapy for Prostate Cancer: An Evaluation of Clinical Feasibility and Dosimetric Outcomes" @default.
- W2913205887 cites W1076742793 @default.
- W2913205887 cites W1996809772 @default.
- W2913205887 cites W1998243921 @default.
- W2913205887 cites W1999045406 @default.
- W2913205887 cites W2014223965 @default.
- W2913205887 cites W2037565714 @default.
- W2913205887 cites W2054899405 @default.
- W2913205887 cites W2072653737 @default.
- W2913205887 cites W2145027378 @default.
- W2913205887 cites W2159598747 @default.
- W2913205887 cites W2282402220 @default.
- W2913205887 cites W2290034687 @default.
- W2913205887 cites W2553678345 @default.
- W2913205887 cites W2569728867 @default.
- W2913205887 cites W2581304576 @default.
- W2913205887 cites W2593204990 @default.
- W2913205887 cites W2611292829 @default.
- W2913205887 cites W2740606439 @default.
- W2913205887 cites W2768304884 @default.
- W2913205887 cites W4254486612 @default.
- W2913205887 doi "https://doi.org/10.7759/cureus.4085" @default.
- W2913205887 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6467540" @default.
- W2913205887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31019863" @default.
- W2913205887 hasPublicationYear "2019" @default.
- W2913205887 type Work @default.
- W2913205887 sameAs 2913205887 @default.
- W2913205887 citedByCount "0" @default.
- W2913205887 crossrefType "journal-article" @default.
- W2913205887 hasAuthorship W2913205887A5008727313 @default.
- W2913205887 hasAuthorship W2913205887A5029947606 @default.
- W2913205887 hasAuthorship W2913205887A5030221717 @default.
- W2913205887 hasAuthorship W2913205887A5033055858 @default.
- W2913205887 hasAuthorship W2913205887A5037101951 @default.
- W2913205887 hasAuthorship W2913205887A5072025238 @default.
- W2913205887 hasAuthorship W2913205887A5073004665 @default.
- W2913205887 hasAuthorship W2913205887A5073891143 @default.
- W2913205887 hasAuthorship W2913205887A5080360470 @default.
- W2913205887 hasAuthorship W2913205887A5087919687 @default.
- W2913205887 hasBestOaLocation W29132058871 @default.
- W2913205887 hasConcept C105572291 @default.
- W2913205887 hasConcept C121608353 @default.
- W2913205887 hasConcept C126322002 @default.
- W2913205887 hasConcept C126838900 @default.
- W2913205887 hasConcept C141071460 @default.
- W2913205887 hasConcept C143409427 @default.
- W2913205887 hasConcept C201645570 @default.
- W2913205887 hasConcept C2776235491 @default.
- W2913205887 hasConcept C2777416452 @default.
- W2913205887 hasConcept C2777957205 @default.
- W2913205887 hasConcept C2778648096 @default.
- W2913205887 hasConcept C2780192828 @default.
- W2913205887 hasConcept C2781074409 @default.
- W2913205887 hasConcept C2989005 @default.
- W2913205887 hasConcept C509974204 @default.
- W2913205887 hasConcept C71924100 @default.
- W2913205887 hasConcept C75088862 @default.
- W2913205887 hasConceptScore W2913205887C105572291 @default.
- W2913205887 hasConceptScore W2913205887C121608353 @default.
- W2913205887 hasConceptScore W2913205887C126322002 @default.
- W2913205887 hasConceptScore W2913205887C126838900 @default.
- W2913205887 hasConceptScore W2913205887C141071460 @default.
- W2913205887 hasConceptScore W2913205887C143409427 @default.
- W2913205887 hasConceptScore W2913205887C201645570 @default.
- W2913205887 hasConceptScore W2913205887C2776235491 @default.
- W2913205887 hasConceptScore W2913205887C2777416452 @default.
- W2913205887 hasConceptScore W2913205887C2777957205 @default.
- W2913205887 hasConceptScore W2913205887C2778648096 @default.
- W2913205887 hasConceptScore W2913205887C2780192828 @default.
- W2913205887 hasConceptScore W2913205887C2781074409 @default.
- W2913205887 hasConceptScore W2913205887C2989005 @default.
- W2913205887 hasConceptScore W2913205887C509974204 @default.
- W2913205887 hasConceptScore W2913205887C71924100 @default.
- W2913205887 hasConceptScore W2913205887C75088862 @default.
- W2913205887 hasLocation W29132058871 @default.
- W2913205887 hasLocation W29132058872 @default.
- W2913205887 hasLocation W29132058873 @default.
- W2913205887 hasOpenAccess W2913205887 @default.
- W2913205887 hasPrimaryLocation W29132058871 @default.
- W2913205887 hasRelatedWork W1995273601 @default.
- W2913205887 hasRelatedWork W2001965487 @default.
- W2913205887 hasRelatedWork W2016844936 @default.
- W2913205887 hasRelatedWork W2027294118 @default.
- W2913205887 hasRelatedWork W2039692113 @default.
- W2913205887 hasRelatedWork W2048324982 @default.
- W2913205887 hasRelatedWork W2051134228 @default.